SLB, Johnson & Johnson And 2 Other Stocks Insiders Are Selling
Portfolio Pulse from Lisa Levin
Insiders at Johnson & Johnson (JNJ), Schlumberger Limited (SLB), Capital One Financial Corporation (COF), and Kimberly-Clark Corporation (KMB) have recently sold significant amounts of shares. While insider sales can sometimes indicate concern about a company's prospects, they can also be part of preplanned sales and should not be the sole basis for investment decisions.
July 28, 2023 | 11:56 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Capital One's Senior Advisor to the CEO sold 9,790 shares. The company reported a slight increase in Q2 revenue, missing estimates.
The insider sale and missed revenue estimates could potentially have a negative impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Kimberly-Clark's Chief Legal Officer sold 4,423 shares. The company reported a slight increase in Q2 sales, missing estimates.
The insider sale and missed sales estimates could potentially have a negative impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Schlumberger's Chief Accounting Officer sold 17,500 shares. The company reported mixed Q2 results.
The insider sale, combined with mixed Q2 results, could potentially have a negative impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Johnson & Johnson's Exec VP sold 20,000 shares. The company recently reported better-than-expected Q2 results and raised its FY23 guidance.
While the insider sale could be seen as a negative signal, the company's strong performance and raised guidance could offset this in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100